• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光化性角化病和鳞状细胞癌:临床及病理特征

Actinic keratosis and squamous cell carcinoma: clinical and pathological features.

作者信息

Filosa A, Filosa G

机构信息

Section of Pathological Anatomy, Macerata Hospital Area Vasta 3, ASUR Marche, Macerata, Italy -

出版信息

G Ital Dermatol Venereol. 2015 Aug;150(4):379-84. Epub 2015 Jun 23.

PMID:26099352
Abstract

Actinic keratoses (AKs) are the most common keratinocytederived precancerous lesion in humans; they can be observed predominantly in fair-skinned individuals on sun-exposed surfaces. The primary risk factor for AKs is cumulative UV exposure from sunlight and/or tanning salons. AKs may present on a patient as a few detectable lesions. In addition to these, there are subclinical (invisible) AKs that are estimated to occur up to 10 times more often than visible AKs, since unprotected skin receives UV radiation from the sun. Clinical and subclinical AK lesions occurring in photo-damaged skin are called field cancerization. A field of change can be up to 7 cm around the primary lesions, resulting in lesions that are genetically similar. AKs are defined at the histologic level by dysplasia and consist of keratinocytes manifesting atypical nuclei that are enlarged, irregular, and hyperchromatic. The histopathologic changes noted in keratinocytic proliferative lesions involve disturbance of normal surface maturation. The degree and extent of keratinocytic atypia vary in these lesions. The atypical keratinocytes show enlarged nuclei with hyperchromasia, dyskeratosis and mitoses in any layer of the epidermis. In lesions of epidermal dysplasias, surface keratinocytic maturation is present, and a granular cell layer is usually noted. In intraepidermal carcinomas, there is full-thickness involvement of the epidermis by the atypical keratinocytes. While molecular techniques have improved our ability to distinguish squamous cell carcinomas (SCCs) from AKs, they have also reinforced the concept that non-melanoma skin cancers arise through a complex series of aberrations at the molecular level. AKs represent a spectrum along the continuum to invasive cancer. They are the most visible manifestation of field cancerization which creates a population of atypical cells with the potential to progress to invasive malignancy capable of metastasis. As the perilesional epithelium also has abnormalities due to photo exposure, understanding the existence of a "cancerization field" should be explained to the patients, reinforcing the importance of preventive clinical follow-up. The aim of the present review was to emphasize the histopathological aspect of the morphological spectrum in AK, and SCCs, also elucidating the clinicopathology of field canceriziation.

摘要

光化性角化病(AKs)是人类最常见的角质形成细胞来源的癌前病变;主要见于皮肤白皙者暴露于阳光下的部位。AKs的主要危险因素是阳光和/或晒黑沙龙的累积紫外线暴露。AKs在患者身上可能表现为少数可检测到的病变。除此之外,还有亚临床(不可见)AKs,据估计其发生频率比可见AKs高10倍,因为未受保护的皮肤会受到来自太阳的紫外线辐射。发生在光损伤皮肤中的临床和亚临床AK病变被称为场癌化。病变周围的变化范围可达7厘米,导致病变在基因上相似。AKs在组织学水平上由发育异常定义,由表现出非典型细胞核的角质形成细胞组成,这些细胞核增大、不规则且染色质增多。在角质形成细胞增殖性病变中观察到的组织病理学变化涉及正常表面成熟的紊乱。这些病变中角质形成细胞异型性的程度和范围各不相同。非典型角质形成细胞显示细胞核增大,伴有染色质增多、角化不良和表皮各层的有丝分裂。在表皮发育异常的病变中,存在表面角质形成细胞成熟,通常可见颗粒细胞层。在表皮内癌中,非典型角质形成细胞累及表皮全层。虽然分子技术提高了我们区分鳞状细胞癌(SCCs)和AKs的能力,但它们也强化了非黑色素瘤皮肤癌是通过分子水平上一系列复杂畸变产生的这一概念。AKs代表了向浸润性癌发展过程中的一个连续谱。它们是场癌化最明显的表现,场癌化产生了一群具有发展为能够转移的浸润性恶性肿瘤潜力的非典型细胞。由于病变周围的上皮也因光照而存在异常,应向患者解释“癌化场”的存在,强调预防性临床随访的重要性。本综述的目的是强调AK和SCC形态谱的组织病理学方面,同时阐明场癌化的临床病理学。

相似文献

1
Actinic keratosis and squamous cell carcinoma: clinical and pathological features.光化性角化病和鳞状细胞癌:临床及病理特征
G Ital Dermatol Venereol. 2015 Aug;150(4):379-84. Epub 2015 Jun 23.
2
[Beyond actinic keratoses: Field cancerization of the skin].[超越光化性角化病:皮肤的场癌化]
Ann Dermatol Venereol. 2018 Oct;145(10):587-592. doi: 10.1016/j.annder.2018.06.009. Epub 2018 Sep 20.
3
Pathology and pathobiology of actinic (solar) keratosis - an update.光化性(日光性)角化病的病理学与病理生物学——最新进展
Br J Dermatol. 2007 Dec;157 Suppl 2:18-20. doi: 10.1111/j.1365-2133.2007.08267.x.
4
The many clinico-pathologic faces of actinic keratosis: an atlas.光化性角化病的多种临床病理表现:图谱集
Curr Probl Dermatol. 2015;46:64-9. doi: 10.1159/000366538. Epub 2014 Dec 18.
5
Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses.皮肤鳞状细胞癌与基底细胞增生性光化性角化病有关。
Br J Dermatol. 2019 Apr;180(4):916-921. doi: 10.1111/bjd.16536. Epub 2018 Jun 29.
6
[Actinic Keratosis].[光化性角化病]
Laryngorhinootologie. 2015 Jul;94(7):467-79; quiz 480-1. doi: 10.1055/s-0035-1554655. Epub 2015 Jun 30.
7
[The real face of actinic keratosis: field of cancerisation and squamous cell carcinoma].[光化性角化病的真面目:癌变区域与鳞状细胞癌]
Eur J Dermatol. 2012 Dec;22 Suppl 1:5-9. doi: 10.1684/ejd.2012.1872.
8
Topical management of actinic keratosis and field cancerisation.光化性角化病和癌前病变的局部治疗。
G Ital Dermatol Venereol. 2009 Aug;144(4):459-62.
9
Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis").早期表皮内鳞状细胞癌(“光化性角化病”)的组织病理学
J Am Acad Dermatol. 2000 Jan;42(1 Pt 2):11-7. doi: 10.1067/mjd.2000.103344.
10
Reflectance confocal microscopy criteria for squamous cell carcinomas and actinic keratoses.鳞状细胞癌和光化性角化病的反射式共聚焦显微镜检查标准。
Arch Dermatol. 2009 Jul;145(7):766-72. doi: 10.1001/archdermatol.2009.134.

引用本文的文献

1
Clinical and Dermoscopic Diagnosis of Actinic Keratosis.光化性角化病的临床与皮肤镜诊断
Dermatol Pract Concept. 2024 Jul 1;14(3 S1):e2024147S. doi: 10.5826/dpc.1403S1a147S.
2
Grading differentiation in cutaneous squamous cell carcinoma: a review of the literature.皮肤鳞状细胞癌的分级分化:文献复习。
Arch Dermatol Res. 2024 Jun 27;316(7):434. doi: 10.1007/s00403-024-03184-w.
3
New Insights into the Role of PPARγ in Skin Physiopathology.PPARγ 在皮肤生理病理中的作用新见解。
Biomolecules. 2024 Jun 19;14(6):728. doi: 10.3390/biom14060728.
4
An Insight on Skin Cancer About Different Targets With Update on Clinical Trials and Investigational Drugs.皮肤癌的不同靶点研究进展及临床试验和在研药物概述
Curr Drug Deliv. 2024;21(6):852-869. doi: 10.2174/1567201820666230726150642.
5
Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) Project.专家关于促进光化性角化病长期个体化管理方法的建议:光化性角化病个体化治疗(PAKT)项目。
Acta Derm Venereol. 2023 Jun 8;103:adv6229. doi: 10.2340/actadv.v103.6229.
6
The Activation of PPARγ by (2Z,4E,6E)-2-methoxyocta-2,4,6-trienoic Acid Counteracts the Epithelial-Mesenchymal Transition Process in Skin Carcinogenesis.(2Z,4E,6E)-2-甲氧基-辛-2,4,6-三烯酸激活 PPARγ 可拮抗皮肤癌变过程中的上皮-间充质转化。
Cells. 2023 Mar 24;12(7):1007. doi: 10.3390/cells12071007.
7
New insights from non-invasive imaging: from prospection of skin photodamages to training with mobile application.非侵入性成像的新见解:从皮肤光损伤的预测到移动应用的训练。
J Eur Acad Dermatol Venereol. 2022 Jun;36 Suppl 6(Suppl 6):38-50. doi: 10.1111/jdv.18197.
8
Significant Biomarkers Identification Associated with Cutaneous Squamous Cell Carcinoma Progression.与皮肤鳞状细胞癌进展相关的重要生物标志物的鉴定
Int J Gen Med. 2022 Mar 2;15:2347-2360. doi: 10.2147/IJGM.S357022. eCollection 2022.
9
Identification of key genes in cutaneous squamous cell carcinoma: a transcriptome sequencing and bioinformatics profiling study.皮肤鳞状细胞癌关键基因的鉴定:一项转录组测序与生物信息学分析研究
Ann Transl Med. 2021 Oct;9(19):1497. doi: 10.21037/atm-21-3915.
10
Protective effects of sunscreen (50+) and octatrienoic acid 0.1% in actinic keratosis and UV damages.防晒(50+)和 0.1%十八碳八烯酸对光化性角化病和紫外线损伤的保护作用。
J Investig Med. 2022 Jan;70(1):92-98. doi: 10.1136/jim-2021-001972. Epub 2021 Sep 16.